The calcilytics Calhex-231 and NPS 2143 and the calcimimetic Calindol reduce vascular reactivity via inhibition of voltage-gated Ca2+ channels
- Eur J Pharmacol. 2016 Nov 15;791:659-668. doi: 10.1016/j.ejphar.2016.10.008.
- 1. Vascular Biology Research Centre, Institute of Cardiovascu lar & Cell Sciences, St. George's, University of London, Cranmer Terrace, London SW17 0RE, UK. Electronic address: [email protected].
- 2. Vascular Biology Research Centre, Institute of Cardiovascu lar & Cell Sciences, St. George's, University of London, Cranmer Terrace, London SW17 0RE, UK.
The present study investigates the effect of commonly used negative and positive allosteric modulators of the calcium-sensing receptor (CaSR) on vascular reactivity. In wire myography studies, increasing [CA2+]o from 1mM to 6mM induced concentration-dependent relaxations of methoxamine-induced pre-contracted rabbit mesenteric arteries, with 6mM [CA2+]o producing almost complete relaxation. [CA2+]o-induced relaxations were attenuated in the presence of the calcilytics Calhex-231 and NPS 2143, and abolished by the removal of the endothelium. In addition to their calcilytic effects, Calhex-231 and NPS 2143 also produced concentration-dependent inhibitions of methoxamine- or KCl-induced precontracted tone, which were unaffected by removal of the endothelium and unopposed in the presence of the calcimimetic Calindol. In vessels with depleted CA2+ stores, contractions mediated by CA2+ influx via voltage-gated CA2+ channels (VGCCs) were inhibited by Calhex231. In freshly isolated single rabbit mesenteric artery smooth muscle cells, Calhex-231 and NPS 2143 inhibited whole-cell VGCC currents. Application of Calindol also inhibited methoxamine- and KCl-induced pre-contracted tone, and inhibited whole-cell VGCC currents. In conclusion, in addition to their CaSR-mediated actions in the vasculature, Calhex-231, NPS 2143 and Calindol reduce vascular contractility via direct inhibition of VGCCs.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: CaSRResearch Areas: Cardiovascular Disease
-
Research Areas: Cardiovascular Disease